International Clinical Trial: An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07807969) titled 'An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)' on Sept. 3.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Annexon, Inc.

Condition: Geographic Atrophy

Intervention: Drug: Vonaprument

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: September 30, 2026

Target Sample Size: 605

Countries of Recruitment: United States

To know more...